Company page

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (Ticker: AUPH) is a public company based in the United States, focused on developing innovative therapies for kidney diseases. With a market capitalization of approximately $1.97 billion, Aurinia is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company is committed to addressing unmet medical needs in the healthcare sector.